1Antony VB. Immunological mechanisms in pleural disease. Eur Respir J, 2003,21 (3) : 539-544.
2Beavis J, Harwood JL, Coles GA, et al. Synthesis of phospholipids by human peritoneal mesothelial cells. Perit Dial Int,1994,14(4) :348-355.
3Mutsaers SE. Mesothelial cells:their structure, function and role in serosal repair. Respirology,2002,7(3) : 171-191.
4Huggins JT, Sahn SA. Causes and management of pleural fibrosis. Respirology, 2004,9 (4) : 441-447.
5Whitaker D,Papadimitriou JM, Waiters M. The mesothelium: a histochemical study of resting mesothelial cells. J Pathol, 1980,132(3) :273-284.
6Yano S, Shinoajara S, Herpst RS, et al. Production of experimental malignant pleural effusion is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells.Am J Pathol,2000,157(6) :898-903.
7Idell S. Coagulation, fibrinolysis and fibrin deposition in lung injury and repair. Pulmonary Fibrosis,1995,80(4) :743-776.
8Coxon A,Tang T, Mayadas TN. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte/macrophage colony-stimulating factor. J Exp Med,1999,190(7) :923-934.
9Jonjic N, Peri G, Bernasconi S, et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med,1992,176(4):1165-1174.
10Mutsaers SE, Prele CM, Brody AR. Pathogenesis of pleural fibrosis. Respirology, 2004,9 (4) : 428-440.
